1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Lions Vision Resource Network (LVRN) Grants for the Blind or Low Vision (Dr. Maureen Powers Quality-of-Life Grant) is sponsored by Lions Vision Resource Network (LVRN). These grants provide financial aid to local blind or low vision individuals to improve their quality of life. Organizations that provide services to people who are blind or low vision in Alameda or Contra Costa Counties in California are eligible to apply.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations that provide services to people who are blind or low vision in Alameda or Contra Costa Counties in California. Confirm the full requirements in the official notice before applying.
The current listing shows up to $5,000 per grant. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Lions Vision Resource Network (LVRN) Grants for the Blind or Low Vision (Dr. Maureen Powers Quality-of-Life Grant) is funded by Lions Vision Resource Network (LVRN). Verify program details on the funder's official page before applying.
This opportunity targets applicants in California. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
RFA-AI-28-005 recompetes NIAID's Immune Tolerance Network as a single UM1 cooperative agreement: $27M committed in FY2028, budgets capped at $23M a year in direct costs, a mandatory 7-year project period, one application per institution, and a January 29, 2027 deadline. The winner inherits roughly 20 ongoing trials and about 200 sub-agreements.
Read articleThe All of Us X01 is a Resource Access Award, not a funding award. It conveys serum, plasma and genomic DNA from a 613,000-participant biobank, requires you to prove you already have the money, and gives you nine months of exclusivity before your own assay data goes public.
Read articleOn September 29, 2026, USDA raised the Regenerative Pilot Program to $1 billion for FY 2027: $650 million through EQIP, $350 million through CSP. The headline is the money. The decisive change is CSP's resource-concern threshold dropping from 100 percent to 75 percent, and the fact that EQIP absorbed nearly all the growth.
Read article